25 XP   0   0   10

Galenica Sante AG
Buy, Hold or Sell?

Let's analyse Galenica together

PenkeI guess you are interested in Galenica Sante AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Galenica Sante AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Galenica Sante AG

I send you an email if I find something interesting about Galenica Sante AG.

Quick analysis of Galenica (30 sec.)










What can you expect buying and holding a share of Galenica? (30 sec.)

How much money do you get?

How much money do you get?
CHF9.66
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
CHF29.57
Expected worth in 1 year
CHF47.54
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
CHF26.81
Return On Investment
38.1%

For what price can you sell your share?

Current Price per Share
CHF70.35
Expected price per share
CHF69.30 - CHF73.45
How sure are you?
50%

1. Valuation of Galenica (5 min.)




Live pricePrice per Share (EOD)

CHF70.35

Intrinsic Value Per Share

CHF23.36 - CHF34.05

Total Value Per Share

CHF52.93 - CHF63.62

2. Growth of Galenica (5 min.)




Is Galenica growing?

Current yearPrevious yearGrowGrow %
How rich?$1.6b$1.3b$246.7m15.3%

How much money is Galenica making?

Current yearPrevious yearGrowGrow %
Making money$189.7m$180.5m$9.2m4.9%
Net Profit Margin4.6%4.1%--

How much money comes from the company's main activities?

3. Financial Health of Galenica (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  

What can you expect buying and holding a share of Galenica? (5 min.)

Welcome investor! Galenica's management wants to use your money to grow the business. In return you get a share of Galenica.

What can you expect buying and holding a share of Galenica?

First you should know what it really means to hold a share of Galenica. And how you can make/lose money.

Speculation

The Price per Share of Galenica is CHF70.35. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Galenica.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Galenica, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is CHF29.57. Based on the TTM, the Book Value Change Per Share is CHF4.49 per quarter. Based on the YOY, the Book Value Change Per Share is CHF0.32 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is CHF2.21 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Galenica.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 CHF% of Price per ShareCHF% of Price per ShareCHF% of Price per ShareCHF% of Price per ShareCHF% of Price per Share
Usd Eps3.805.4%3.805.4%3.625.1%3.535.0%2.894.1%
Usd Book Value Change Per Share4.917.0%4.917.0%0.350.5%2.373.4%3.234.6%
Usd Dividend Per Share2.423.4%2.423.4%2.303.3%2.103.0%3.234.6%
Usd Total Gains Per Share7.3310.4%7.3310.4%2.653.8%4.466.3%6.469.2%
Usd Price Per Share79.53-79.53-82.59-73.40-46.90-
Price to Earnings Ratio20.91-20.91-22.80-21.00-14.06-
Price-to-Total Gains Ratio10.85-10.85-31.22-19.04-15.89-
Price to Book Ratio2.46-2.46-3.01-2.80-1.92-
Price-to-Total Gains Ratio10.85-10.85-31.22-19.04-15.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share76.90662
Number of shares13
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share2.422.10
Usd Book Value Change Per Share4.912.37
Usd Total Gains Per Share7.334.46
Gains per Quarter (13 shares)95.2658.03
Gains per Year (13 shares)381.02232.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1126255371109123222
2251511752218246454
33777661133327369686
450310221514436493918
5628127718955456161150
6754153222766547391382
7879178826577638621614
81005204330388729851846
911312299341998111082078
10125625543800109012312310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%

Fundamentals of Galenica

About Galenica Sante AG

Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers master data system for the healthcare market; develops management solutions for the healthcare market; group internal IT services; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Fundamental data was last updated by Penke on 2024-04-21 17:54:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Galenica Sante AG.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Galenica earns for each CHF1 of revenue.

  • Above 10% is considered healthy but always compare Galenica to the Medical Distribution industry mean.
  • A Net Profit Margin of 4.6% means that CHF0.05 for each CHF1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Galenica Sante AG:

  • The MRQ is 4.6%. The company is making a profit. +1
  • The TTM is 4.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.6%TTM4.6%0.0%
TTM4.6%YOY4.1%+0.5%
TTM4.6%5Y4.4%+0.3%
5Y4.4%10Y3.9%+0.5%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6%2.0%+2.6%
TTM4.6%2.1%+2.5%
YOY4.1%2.5%+1.6%
5Y4.4%2.2%+2.2%
10Y3.9%2.1%+1.8%
1.1.2. Return on Assets

Shows how efficient Galenica is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Galenica to the Medical Distribution industry mean.
  • 5.7% Return on Assets means that Galenica generated CHF0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Galenica Sante AG:

  • The MRQ is 5.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.7%TTM5.7%0.0%
TTM5.7%YOY6.2%-0.5%
TTM5.7%5Y6.3%-0.6%
5Y6.3%10Y6.0%+0.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7%0.9%+4.8%
TTM5.7%0.9%+4.8%
YOY6.2%1.2%+5.0%
5Y6.3%1.0%+5.3%
10Y6.0%1.1%+4.9%
1.1.3. Return on Equity

Shows how efficient Galenica is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Galenica to the Medical Distribution industry mean.
  • 11.8% Return on Equity means Galenica generated CHF0.12 for each CHF1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Galenica Sante AG:

  • The MRQ is 11.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.8%TTM11.8%0.0%
TTM11.8%YOY13.3%-1.5%
TTM11.8%5Y13.5%-1.8%
5Y13.5%10Y19.0%-5.5%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ11.8%2.4%+9.4%
TTM11.8%2.4%+9.4%
YOY13.3%2.4%+10.9%
5Y13.5%2.4%+11.1%
10Y19.0%2.9%+16.1%

1.2. Operating Efficiency of Galenica Sante AG.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Galenica is operating .

  • Measures how much profit Galenica makes for each CHF1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Galenica to the Medical Distribution industry mean.
  • An Operating Margin of 4.9% means the company generated CHF0.05  for each CHF1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Galenica Sante AG:

  • The MRQ is 4.9%. The company is operating less efficient.
  • The TTM is 4.9%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ4.9%TTM4.9%0.0%
TTM4.9%YOY4.8%+0.1%
TTM4.9%5Y5.1%-0.1%
5Y5.1%10Y4.5%+0.6%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9%3.3%+1.6%
TTM4.9%2.6%+2.3%
YOY4.8%3.4%+1.4%
5Y5.1%3.4%+1.7%
10Y4.5%3.1%+1.4%
1.2.2. Operating Ratio

Measures how efficient Galenica is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 0.95 means that the operating costs are CHF0.95 for each CHF1 in net sales.

Let's take a look of the Operating Ratio trends of Galenica Sante AG:

  • The MRQ is 0.951. The company is less efficient in keeping operating costs low.
  • The TTM is 0.951. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.951TTM0.9510.000
TTM0.951YOY0.952-0.001
TTM0.9515Y0.949+0.002
5Y0.94910Y0.955-0.006
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9511.618-0.667
TTM0.9511.515-0.564
YOY0.9521.422-0.470
5Y0.9491.246-0.297
10Y0.9551.155-0.200

1.3. Liquidity of Galenica Sante AG.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Galenica is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.34 means the company has CHF1.34 in assets for each CHF1 in short-term debts.

Let's take a look of the Current Ratio trends of Galenica Sante AG:

  • The MRQ is 1.338. The company is just able to pay all its short-term debts.
  • The TTM is 1.338. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.338TTM1.3380.000
TTM1.338YOY1.110+0.229
TTM1.3385Y1.374-0.035
5Y1.37410Y1.430-0.056
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3381.374-0.036
TTM1.3381.398-0.060
YOY1.1101.424-0.314
5Y1.3741.401-0.027
10Y1.4301.350+0.080
1.3.2. Quick Ratio

Measures if Galenica is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Galenica to the Medical Distribution industry mean.
  • A Quick Ratio of 0.82 means the company can pay off CHF0.82 for each CHF1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Galenica Sante AG:

  • The MRQ is 0.822. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.822. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.822TTM0.8220.000
TTM0.822YOY0.511+0.310
TTM0.8225Y0.754+0.068
5Y0.75410Y0.796-0.042
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8220.738+0.084
TTM0.8220.751+0.071
YOY0.5110.807-0.296
5Y0.7540.788-0.034
10Y0.7960.855-0.059

1.4. Solvency of Galenica Sante AG.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Galenica assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Galenica to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.52 means that Galenica assets are financed with 51.5% credit (debt) and the remaining percentage (100% - 51.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Galenica Sante AG:

  • The MRQ is 0.515. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.515. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.515TTM0.5150.000
TTM0.515YOY0.531-0.016
TTM0.5155Y0.531-0.016
5Y0.53110Y0.622-0.090
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5150.614-0.099
TTM0.5150.608-0.093
YOY0.5310.600-0.069
5Y0.5310.595-0.064
10Y0.6220.594+0.028
1.4.2. Debt to Equity Ratio

Measures if Galenica is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Galenica to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 106.5% means that company has CHF1.06 debt for each CHF1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Galenica Sante AG:

  • The MRQ is 1.065. The company is able to pay all its debts with equity. +1
  • The TTM is 1.065. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.065TTM1.0650.000
TTM1.065YOY1.135-0.070
TTM1.0655Y1.139-0.074
5Y1.13910Y2.497-1.358
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0651.558-0.493
TTM1.0651.630-0.565
YOY1.1351.697-0.562
5Y1.1391.704-0.565
10Y2.4971.760+0.737

2. Market Valuation of Galenica Sante AG

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every CHF1 in earnings Galenica generates.

  • Above 15 is considered overpriced but always compare Galenica to the Medical Distribution industry mean.
  • A PE ratio of 20.91 means the investor is paying CHF20.91 for every CHF1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Galenica Sante AG:

  • The EOD is 20.220. Based on the earnings, the company is fair priced.
  • The MRQ is 20.910. Based on the earnings, the company is fair priced.
  • The TTM is 20.910. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD20.220MRQ20.910-0.690
MRQ20.910TTM20.9100.000
TTM20.910YOY22.799-1.889
TTM20.9105Y21.002-0.093
5Y21.00210Y14.062+6.940
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD20.22012.498+7.722
MRQ20.91013.542+7.368
TTM20.91015.818+5.092
YOY22.79918.843+3.956
5Y21.00215.030+5.972
10Y14.06221.149-7.087
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Galenica Sante AG:

  • The EOD is 23.505. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 24.307. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 24.307. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD23.505MRQ24.307-0.802
MRQ24.307TTM24.3070.000
TTM24.307YOY22.611+1.696
TTM24.3075Y18.402+5.905
5Y18.40210Y12.816+5.586
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD23.5057.031+16.474
MRQ24.3079.109+15.198
TTM24.30712.435+11.872
YOY22.6110.763+21.848
5Y18.4023.139+15.263
10Y12.8164.036+8.780
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Galenica is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 2.46 means the investor is paying CHF2.46 for each CHF1 in book value.

Let's take a look of the Price to Book Ratio trends of Galenica Sante AG:

  • The EOD is 2.379. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.461. Based on the equity, the company is underpriced. +1
  • The TTM is 2.461. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.379MRQ2.461-0.081
MRQ2.461TTM2.4610.000
TTM2.461YOY3.013-0.553
TTM2.4615Y2.804-0.343
5Y2.80410Y1.922+0.881
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD2.3790.995+1.384
MRQ2.4611.119+1.342
TTM2.4611.133+1.328
YOY3.0131.302+1.711
5Y2.8041.297+1.507
10Y1.9222.044-0.122
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Galenica Sante AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.4934.4930%0.317+1318%2.166+107%2.957+52%
Book Value Per Share--29.56629.5660%25.073+18%24.118+23%17.329+71%
Current Ratio--1.3381.3380%1.110+21%1.374-3%1.430-6%
Debt To Asset Ratio--0.5150.5150%0.531-3%0.531-3%0.622-17%
Debt To Equity Ratio--1.0651.0650%1.135-6%1.139-7%2.497-57%
Dividend Per Share--2.2102.2100%2.103+5%1.917+15%2.952-25%
Eps--3.4793.4790%3.314+5%3.225+8%2.639+32%
Free Cash Flow Per Share--2.9932.9930%3.341-10%3.830-22%2.949+2%
Free Cash Flow To Equity Per Share--1.4091.4090%-0.296+121%1.143+23%1.008+40%
Gross Profit Margin--0.7580.7580%0.526+44%0.692+9%0.566+34%
Intrinsic Value_10Y_max--34.050--------
Intrinsic Value_10Y_min--23.359--------
Intrinsic Value_1Y_max--3.833--------
Intrinsic Value_1Y_min--3.490--------
Intrinsic Value_3Y_max--11.196--------
Intrinsic Value_3Y_min--9.552--------
Intrinsic Value_5Y_max--18.172--------
Intrinsic Value_5Y_min--14.545--------
Market Cap3505695270.000-4%3629857248.7503629857248.7500%3764822710.000-4%3346646847.750+8%2138407346.475+70%
Net Profit Margin--0.0460.0460%0.041+13%0.044+6%0.039+20%
Operating Margin--0.0490.0490%0.048+3%0.051-2%0.045+9%
Operating Ratio--0.9510.9510%0.9520%0.949+0%0.9550%
Pb Ratio2.379-3%2.4612.4610%3.013-18%2.804-12%1.922+28%
Pe Ratio20.220-3%20.91020.9100%22.799-8%21.0020%14.062+49%
Price Per Share70.350-3%72.75072.7500%75.550-4%67.140+8%42.903+70%
Price To Free Cash Flow Ratio23.505-3%24.30724.3070%22.611+8%18.402+32%12.816+90%
Price To Total Gains Ratio10.496-3%10.85410.8540%31.219-65%19.038-43%15.886-32%
Quick Ratio--0.8220.8220%0.511+61%0.754+9%0.796+3%
Return On Assets--0.0570.0570%0.062-8%0.063-10%0.060-5%
Return On Equity--0.1180.1180%0.133-11%0.135-13%0.190-38%
Total Gains Per Share--6.7036.7030%2.420+177%4.083+64%5.909+13%
Usd Book Value--1612684267.2001612684267.2000%1365910765.200+18%1314295108.560+23%944525127.960+71%
Usd Book Value Change Per Share--4.9114.9110%0.346+1318%2.368+107%3.232+52%
Usd Book Value Per Share--32.32232.3220%27.410+18%26.366+23%18.944+71%
Usd Dividend Per Share--2.4162.4160%2.299+5%2.095+15%3.227-25%
Usd Eps--3.8043.8040%3.623+5%3.525+8%2.885+32%
Usd Free Cash Flow--163254115.200163254115.2000%182025452.400-10%208667392.320-22%160740411.120+2%
Usd Free Cash Flow Per Share--3.2723.2720%3.653-10%4.187-22%3.223+2%
Usd Free Cash Flow To Equity Per Share--1.5401.5400%-0.324+121%1.250+23%1.102+40%
Usd Market Cap3832426069.164-4%3968159944.3343968159944.3340%4115704186.572-4%3658554333.960+8%2337706911.166+70%
Usd Price Per Share76.907-3%79.53079.5300%82.591-4%73.397+8%46.902+70%
Usd Profit--189777333.600189777333.6000%180522302.400+5%175709380.080+8%143901851.520+32%
Usd Revenue--4095139225.2004095139225.2000%4388485233.600-7%4018827961.920+2%3656514589.200+12%
Usd Total Gains Per Share--7.3277.3270%2.646+177%4.464+64%6.459+13%
 EOD+4 -4MRQTTM+0 -0YOY+25 -115Y+25 -1110Y+26 -10

3.2. Fundamental Score

Let's check the fundamental score of Galenica Sante AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.220
Price to Book Ratio (EOD)Between0-12.379
Net Profit Margin (MRQ)Greater than00.046
Operating Margin (MRQ)Greater than00.049
Quick Ratio (MRQ)Greater than10.822
Current Ratio (MRQ)Greater than11.338
Debt to Asset Ratio (MRQ)Less than10.515
Debt to Equity Ratio (MRQ)Less than11.065
Return on Equity (MRQ)Greater than0.150.118
Return on Assets (MRQ)Greater than0.050.057
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Galenica Sante AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.144
Ma 20Greater thanMa 5071.674
Ma 50Greater thanMa 10073.206
Ma 100Greater thanMa 20073.039
OpenGreater thanClose71.050
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Long-term Assets Other  -10,076-781,512-791,5882,475-789,113-125,408-914,521934,95120,430



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CHF. All numbers in thousands.

Summary
Total Assets3,042,252
Total Liabilities1,567,056
Total Stockholder Equity1,471,419
 As reported
Total Liabilities 1,567,056
Total Stockholder Equity+ 1,471,419
Total Assets = 3,042,252

Assets

Total Assets3,042,252
Total Current Assets1,033,590
Long-term Assets2,008,662
Total Current Assets
Cash And Cash Equivalents 116,159
Net Receivables 518,293
Inventory 357,096
Other Current Assets 42,042
Total Current Assets  (as reported)1,033,590
Total Current Assets  (calculated)1,033,590
+/-0
Long-term Assets
Property Plant Equipment 321,266
Goodwill 871,307
Intangible Assets 207,196
Long-term Assets Other 20,430
Long-term Assets  (as reported)2,008,662
Long-term Assets  (calculated)1,420,199
+/- 588,463

Liabilities & Shareholders' Equity

Total Current Liabilities772,269
Long-term Liabilities794,787
Total Stockholder Equity1,471,419
Total Current Liabilities
Short-term Debt 120,715
Accounts payable 384,774
Other Current Liabilities 257,280
Total Current Liabilities  (as reported)772,269
Total Current Liabilities  (calculated)762,769
+/- 9,500
Long-term Liabilities
Capital Lease Obligations 236,041
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)794,787
Long-term Liabilities  (calculated)236,042
+/- 558,745
Total Stockholder Equity
Common Stock5,000
Retained Earnings 1,478,235
Other Stockholders Equity -11,816
Total Stockholder Equity (as reported)1,471,419
Total Stockholder Equity (calculated)1,471,419
+/-0
Other
Capital Stock5,000
Cash and Short Term Investments 116,159
Common Stock Shares Outstanding 49,895
Current Deferred Revenue9,500
Liabilities and Stockholders Equity 3,042,252
Net Debt 658,682
Net Invested Capital 1,471,419
Net Working Capital 261,321
Property Plant and Equipment Gross 885,345
Short Long Term Debt Total 774,841



Balance Sheet

Currency in CHF. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
1,725,924
1,708,943
1,732,714
1,985,532
1,798,182
1,860,088
2,209,579
2,258,938
2,615,712
2,663,679
3,042,252
3,042,2522,663,6792,615,7122,258,9382,209,5791,860,0881,798,1821,985,5321,732,7141,708,9431,725,924
   > Total Current Assets 
778,816
729,906
750,033
1,021,892
788,217
781,536
822,849
812,064
963,496
976,718
1,033,590
1,033,590976,718963,496812,064822,849781,536788,2171,021,892750,033729,906778,816
       Cash And Cash Equivalents 
18,621
22,271
10,500
9,019
96,287
104,970
90,532
59,781
164,982
93,927
116,159
116,15993,927164,98259,78190,532104,97096,2879,01910,50022,27118,621
       Net Receivables 
0
309,817
331,895
699,745
376,691
360,323
405,584
406,360
461,108
529,479
518,293
518,293529,479461,108406,360405,584360,323376,691699,745331,895309,8170
       Inventory 
265,402
275,300
282,673
264,716
274,217
276,628
277,804
306,682
295,070
315,160
357,096
357,096315,160295,070306,682277,804276,628274,217264,716282,673275,300265,402
       Other Current Assets 
494,793
432,335
456,860
748,157
41,022
39,615
48,929
39,241
42,336
38,152
42,042
42,04238,15242,33639,24148,92939,61541,022748,157456,860432,335494,793
   > Long-term Assets 
947,108
979,037
982,681
963,640
994,832
1,040,181
1,364,827
1,446,874
1,652,216
1,686,961
2,008,662
2,008,6621,686,9611,652,2161,446,8741,364,8271,040,181994,832963,640982,681979,037947,108
       Property Plant Equipment 
243,310
245,860
254,267
253,665
251,413
244,990
492,492
478,380
317,851
316,636
321,266
321,266316,636317,851478,380492,492244,990251,413253,665254,267245,860243,310
       Goodwill 
0
580,555
583,268
605,516
633,336
691,473
755,445
791,588
856,113
914,703
871,307
871,307914,703856,113791,588755,445691,473633,336605,516583,268580,5550
       Long Term Investments 
0
44,958
43,273
46,437
50,328
31,667
26,109
0
0
0
0
000026,10931,66750,32846,43743,27344,9580
       Intangible Assets 
0
42,914
40,547
37,574
59,755
76,437
90,781
916,222
1,020,118
1,100,112
207,196
207,1961,100,1121,020,118916,22290,78176,43759,75537,57440,54742,9140
       Long-term Assets Other 
82,900
45,839
37,709
52,019
-6,404
-24,463
-10,076
-791,588
-789,113
-914,521
20,430
20,430-914,521-789,113-791,588-10,076-24,463-6,40452,01937,70945,83982,900
> Total Liabilities 
1,506,217
1,468,679
1,473,523
1,651,327
936,667
926,489
1,210,039
1,205,583
1,382,035
1,414,218
1,567,056
1,567,0561,414,2181,382,0351,205,5831,210,039926,489936,6671,651,3271,473,5231,468,6791,506,217
   > Total Current Liabilities 
635,588
574,216
557,998
771,595
458,061
442,577
553,407
546,780
664,899
880,119
772,269
772,269880,119664,899546,780553,407442,577458,061771,595557,998574,216635,588
       Short-term Debt 
153,463
154,663
138,322
349,908
24,509
29,674
92,426
88,326
92,769
268,637
120,715
120,715268,63792,76988,32692,42629,67424,509349,908138,322154,663153,463
       Short Long Term Debt 
0
155,587
133,485
349,908
24,509
29,674
44,630
0
0
0
0
000044,63029,67424,509349,908133,485155,5870
       Accounts payable 
287,129
309,263
290,334
299,587
262,985
268,972
291,789
289,609
336,201
323,345
384,774
384,774323,345336,201289,609291,789268,972262,985299,587290,334309,263287,129
       Other Current Liabilities 
194,996
110,290
129,342
122,100
162,395
135,873
161,220
161,800
227,954
279,000
257,280
257,280279,000227,954161,800161,220135,873162,395122,100129,342110,290194,996
   > Long-term Liabilities 
870,629
894,463
915,525
879,732
381,219
380,910
380,800
658,803
717,136
534,099
794,787
794,787534,099717,136658,803380,800380,910381,219879,732915,525894,463870,629
       Long term Debt Total 
0
0
0
2,122
381,781
380,910
563,642
552,306
579,878
417,853
0
0417,853579,878552,306563,642380,910381,7812,122000
       Other Liabilities 
0
130,836
151,278
116,110
97,387
103,002
93,060
107,344
112,330
118,851
0
0118,851112,330107,34493,060103,00297,387116,110151,278130,8360
> Total Stockholder Equity
209,733
230,304
254,042
329,621
857,280
929,463
993,497
1,047,282
1,227,538
1,245,580
1,471,419
1,471,4191,245,5801,227,5381,047,282993,497929,463857,280329,621254,042230,304209,733
   Common Stock
0
0
0
0
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,0005,0005,0005,0005,0005,0005,0000000
   Retained Earnings 
209,733
230,305
254,048
329,628
891,000
956,662
1,014,461
1,062,099
1,237,049
1,248,397
1,478,235
1,478,2351,248,3971,237,0491,062,0991,014,461956,662891,000329,628254,048230,305209,733
   Capital Surplus 00000000000
   Treasury Stock00-14,511-19,817-25,964-32,199-38,7200000
   Other Stockholders Equity -11,816-7,817-14,511-19,817-25,964-32,199-38,7200-6-10



Balance Sheet

Currency in CHF. All numbers in thousands.




Cash Flow

Currency in CHF. All numbers in thousands.




Income Statement

Currency in CHF. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,746,011
Cost of Revenue-3,358,416
Gross Profit387,595387,595
 
Operating Income (+$)
Gross Profit387,595
Operating Expense-202,294
Operating Income185,301185,301
 
Operating Expense (+$)
Research Development12,700
Selling General Administrative57,514
Selling And Marketing Expenses42,038
Operating Expense202,294112,252
 
Net Interest Income (+$)
Interest Income1,878
Interest Expense-15,809
Other Finance Cost-76
Net Interest Income-13,855
 
Pretax Income (+$)
Operating Income185,301
Net Interest Income-13,855
Other Non-Operating Income Expenses0
Income Before Tax (EBT)188,111182,491
EBIT - interestExpense = 169,492
202,843
189,407
Interest Expense15,809
Earnings Before Interest and Taxes (EBIT)185,301203,920
Earnings Before Interest and Taxes (EBITDA)288,301
 
After tax Income (+$)
Income Before Tax188,111
Tax Provision-29,245
Net Income From Continuing Ops165,704158,866
Net Income173,598
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,560,710
Total Other Income/Expenses Net2,81013,855
 

Technical Analysis of Galenica
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Galenica. The general trend of Galenica is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Galenica's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Galenica Sante AG.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 71.16 < 71.45 < 73.45.

The bearish price targets are: 69.53 > 69.48 > 69.30.

Tweet this
Galenica Sante AG Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Galenica Sante AG. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Galenica Sante AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Galenica Sante AG. The current macd is -0.79295142.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Galenica price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Galenica. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Galenica price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Galenica Sante AG Daily Moving Average Convergence/Divergence (MACD) ChartGalenica Sante AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Galenica Sante AG. The current adx is 30.72.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Galenica shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Galenica Sante AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Galenica Sante AG. The current sar is 71.87.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Galenica Sante AG Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Galenica Sante AG. The current rsi is 40.14. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Galenica Sante AG Daily Relative Strength Index (RSI) ChartGalenica Sante AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Galenica Sante AG. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Galenica price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Galenica Sante AG Daily Stochastic Oscillator ChartGalenica Sante AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Galenica Sante AG. The current cci is -60.7756196.

Galenica Sante AG Daily Commodity Channel Index (CCI) ChartGalenica Sante AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Galenica Sante AG. The current cmo is -20.05662862.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Galenica Sante AG Daily Chande Momentum Oscillator (CMO) ChartGalenica Sante AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Galenica Sante AG. The current willr is -74.69879518.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Galenica is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Galenica Sante AG Daily Williams %R ChartGalenica Sante AG Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Galenica Sante AG.

Galenica Sante AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Galenica Sante AG. The current atr is 1.00292443.

Galenica Sante AG Daily Average True Range (ATR) ChartGalenica Sante AG Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Galenica Sante AG. The current obv is 1,947,832.

Galenica Sante AG Daily On-Balance Volume (OBV) ChartGalenica Sante AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Galenica Sante AG. The current mfi is 32.91.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Galenica Sante AG Daily Money Flow Index (MFI) ChartGalenica Sante AG Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Galenica Sante AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Galenica Sante AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Galenica Sante AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.144
Ma 20Greater thanMa 5071.674
Ma 50Greater thanMa 10073.206
Ma 100Greater thanMa 20073.039
OpenGreater thanClose71.050
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Galenica with someone you think should read this too:
  • Are you bullish or bearish on Galenica? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Galenica? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Galenica Sante AG

I send you an email if I find something interesting about Galenica Sante AG.


Comments

How you think about this?

Leave a comment

Stay informed about Galenica Sante AG.

Receive notifications about Galenica Sante AG in your mailbox!